Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Multiple Myeloma 152Lymphoma, Mantle-Cell 30Lymphoma, Non-Hodgkin 22Lymphoma, Follicular 22Lymphoma 22Recurrence 21Neoplasms, Plasma Cell 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Leukemia, Myeloid, Acute 12Waldenstrom Macroglobulinemia 11Lymphoma, Large B-Cell, Diffuse 11Immunoglobulin Light-chain Amyloidosis 10Neoplasms 8Lymphoma, B-Cell, Marginal Zone 8Leukemia, Lymphocytic, Chronic, B-Cell 8Lymphoma, B-Cell 7Leukemia 6Carcinoma, Non-Small-Cell Lung 6Myelodysplastic Syndromes 5Hematologic Neoplasms 5Brain Neoplasms 5Amyloidosis 5Lymphoma, Large-Cell, Immunoblastic 4Hematologic Diseases 4Congenital Abnormalities 4Prostatic Neoplasms 3Paraproteinemias 3Leukemia, Myelomonocytic, Acute 3Leukemia, Monocytic, Acute 3Leukemia, Erythroblastic, Acute 3

Interventions

Tretinoin 5Methotrexate 5Tacrolimus 4Arsenic Trioxide 4fludarabine phosphate 3Peripheral Blood Stem Cell Transplantation 3Busulfan 3Mycophenolic Acid 2Mercaptopurine 2Idarubicin 2Gemtuzumab 2Filgrastim 2Cytarabine 2Cyclophosphamide 2Antilymphocyte Serum 2thymoglobulin 1entinostat 1Whole-Body Irradiation 1Vorinostat 1Sorafenib 1Sirolimus 1Granulocyte Colony-Stimulating Factor 1Erlotinib Hydrochloride 1Daunorubicin 1Clofarabine 1Bortezomib 1Biopsy 1Azacitidine 1Alemtuzumab 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leukemia, Promyelocytic, Acute × Bortezomib × Clear all
NCT01465386 2017-04-04

Bortezomib in Treating Patients With High-Risk Acute Myeloid Leukemia in Remission

Fred Hutchinson Cancer Center

Phase 2 Terminated
6 enrolled 8 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡